22.07.2013
- Vivus has agreed to give dissident shareholder First Manhattan a board majority, ending an acrimonious proxy fight and bringing in a new CEO to the drugmaker accused of bungling...
26.06.2013
- First Manhattan Company (FMC) stepped up the pressure in its proxy fight with obesity drug maker Vivus, saying it was in advanced discussions with potential chief executive...
07.01.2013
- Vivus said prescriptions for obesity drug Qsymia, its main product, rose nearly 68% in the month ended Dec. 21 compared with the preceding four weeks, well above industry forecasts...
